Taylor L P, Posner J B
Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Ann Neurol. 1989 Jan;25(1):92-4. doi: 10.1002/ana.410250116.
We reviewed the charts of 429 patients with primary brain tumors treated at Memorial Sloan-Kettering Cancer Center to determine the frequency, clinical characteristics, and provocative factors involved in the development of the shoulder-hand syndrome. Five percent (20/429) of patients developed this syndrome, which was strongly associated with phenobarbital use (p less than 0.0001) and often produced more short-term disability than the brain tumor itself.
我们回顾了纪念斯隆凯特琳癌症中心收治的429例原发性脑肿瘤患者的病历，以确定肩手综合征发生的频率、临床特征及诱发因素。5%（20/429）的患者出现了该综合征，其与使用苯巴比妥密切相关（p<0.0001），且通常比脑肿瘤本身导致更多的短期功能障碍。
